TrevenaLogo.jpg
Trevena Announces Presentations During the 36th Annual Scientific Meeting of the American Pain Society
17 mai 2017 07h00 HE | Trevena Inc.
– Results presented from the successful APOLLO-1 Phase 3 pivotal efficacy study of OLINVOTM (oliceridine injection) in moderate-to-severe acute pain – – New preclinical research highlights the...